Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study
Adverum's (ADVM) stock gains as the FDA lifts the clinical hold on the second cohort of an initial stage study on lead c.....»»
Regulus: FDA lifts Partial Clinical Hold on study of RGLS4326
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AbbVie: FDA lifts partial clinical hold on Phase 3 study of venetoclax
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Advaxis says FDA lifts partial clinical hold on Phase 3 AIM2CERV study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Xencor says FDA lifts partial clinical hold on Phase 1 study of XmAb14045
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Advaxis shares rise 68% after FDA lifts clinical hold on its drug trial
Shares of the biotech company Advaxis Inc. surged 68% in premarket trade on Friday after the Food and Drug Administration lifted a clinical hold on the company's phase 1/2 study for a cancer drug combination. The clinical hol.....»»
FDA lifts hold on Advaxis study of axalimogene filolisbac with durvalumab
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA Lifts Clinical Hold on Epizyme"s Lead Candidate"s Study
The FDA lifts partial clinical hold on Epizyme's lead pipeline candidate, tazemetostat's study. Epizyme, Inc. (EPZM announced that the FDA has lifted the partial clinical hold on its lead cancer candidate tazeme.....»»
Myovant Sciences drops after FDA places partial clinical hold on Phase 3 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Myovant"s stock falls after FDA puts partial clinical hold on trial for contraceptive candidate
Shares of Myovant Sciences Ltd. were down 5.7% in premarket trading on Wednesday after the company told investors that the Food and Drug Administration had placed a partial clinical hold on a study assessing an experimental birth c.....»»
Adverum Biotechnologies downgraded to Hold from Buy at Truist
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Adverum Biotechnologies downgraded to Hold from Buy at Truist
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
AIM ImmunoTech completes dosing of Cohort 2 in Phase 1 study of Ampligen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
UniQure stock is up after FDA lifts clinical hold on experimental gene therapy
Shares of UniQure gai.....»»
UniQure"s Stock Is Trading Higher As FDA Lifts Clinical Hold On Its Hemophilia B Gene Therapy Program
read more.....»»
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma"s Epidiolex
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) read more.....»»
Panbela reports partial clinical hold lifted on Phase 1 study of SBP-101
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
There"s a wealth gap even between millionaires, and it says a lot about growing inequality
Those worth $15 million to $30 million comprise just 16% of very high net worth millionaires, but hold 32% of the cohort's wealth, per Wealth-X. The wealth gap even at the top shows just how .....»»
Leap Therapeutics completes enrollment in first-line cohort of DKN-01 study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
IMAC completes first cohort of Phase 1 study of mesenchymal stem cells
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA lifts partial hold on Pieris Pharmaceuticals" phase 1 studies of PRS-343
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»